brainstem nerve


Hideho Okada, MD, PhD

Previous immunotherapies like CAR T cells were designed to target glioblastoma cells, but were only effective in killing a portion of the cells – leaving some cancer cells behind, and allowing for tumor recurrence.

Top 5 Research Stories of the Year
In 2019, the UCSF Brain Tumor Center researchers focused on therapeutic targets for glioblastoma, immunotherapies, precision medicine clinical trials and more.